Oruka Therapeutics (ORKA) Operating Leases (2020 - 2026)
Oruka Therapeutics' (ORKA) quarterly Operating Leases came in at $1.1 million in Q1 2026, up 69.73% year-on-year from $664000.0 in Q1 2025, and down 14.17% quarter-over-quarter from $1.3 million in Q4 2025.
Oruka Therapeutics (ORKA) Operating Leases (2020 - 2026) Analysis & Trends
Oruka Therapeutics' Operating Leases history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- On a quarterly basis, Operating Leases rose 69.73% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 69.73% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 73.91% from the prior year.
- Operating Leases declined to $1.1 million in Q1 2026 per ORKA's latest filing, from $1.3 million in the prior quarter.
- Across five years, Operating Leases topped out at $1.7 million in Q2 2025 and bottomed at $24000.0 in Q2 2024.
- The 5-year median for Operating Leases is $447500.0 (2022), against an average of $655437.5.
- Across the five-year window, Operating Leases tumbled 92.71% in 2024 and jumped 6841.67% in 2025, its largest moves.
- Year by year, Operating Leases stood at $280000.0 in 2022, then fell by 27.14% to $204000.0 in 2023, then soared by 270.1% to $755000.0 in 2024, then soared by 73.91% to $1.3 million in 2025, then decreased by 14.17% to $1.1 million in 2026.
- Per Business Quant, the three latest ORKA Operating Leases figures stand at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $1.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 664,000.00 |
| Dec 31, 2024 | 755,000.00 |
| Sep 30, 2024 | 842,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Dec 31, 2023 | 204,000.00 |
| Sep 30, 2023 | 224,000.00 |
| Jun 30, 2023 | 329,000.00 |
| Mar 31, 2023 | 262,000.00 |
| Dec 31, 2022 | 280,000.00 |
| Sep 30, 2022 | 409,000.00 |
| Jun 30, 2022 | 435,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Dec 31, 2021 | 383,000.00 |
| Sep 30, 2021 | 410,000.00 |
| Jun 30, 2021 | 435,000.00 |
| Mar 31, 2021 | 450,000.00 |